Building New Nerve Cells in the Brain (2014)

Posted February 15, 2018

mGluR2/3 Blocker Drug

Building on previous work performed by the Cure Alzheimer’s Fund Stem Cell Consortium, Sam Gandy, M.D., Ph.D., at the Icahn School of Medicine at Mt. Sinai conducted studies on a drug called an “mGluR2/3 blocker”, which stimulates the creation of new nerve cells in the brain. Promising pilot results of the drug in mice helped the project secure $1 million in funding from the Veteran’s Administration for additional study.